Skip to content

Clinical trial of COVID-19 drug for severe cases to be carried out at Surrey hospital

Bamlanivimab is designed to block the COVID -19 virus from attaching to and entering human cells
24171531_web1_20210208160212-6021a9d4a9a2da78ad8eba36jpeg

British Columbia will begin a clinical trial on a COVID-19 drug therapy approved by Health Canada on an emergency basis for patients who are at risk of being hospitalized with severe illness.

Provincial health officer Dr. Bonnie Henry said Monday the trial on the drug bamlanivimab, which has been studied elsewhere, is expected to get underway by the beginning of March.

“The clinicians here in B.C. felt they had to better understand who it works best in,” she said.

The drug would be given to patients within a certain time period after diagnosis, involving a one-hour infusion and two hours of observation.

Health Minister Adrian Dix said the trial will be done at Surrey Memorial Hospital with the help of a $1-million donation from a biotech company in B.C.

Bamlanivimab is designed to block the COVID -19 virus from attaching to and entering human cells. Health Canada authorized its use in November.

Henry said she agrees with the province’s ombudsperson that the policy on long-term care visits needs to be more fair and consistent after complaints from those trying to see loved ones during the pandemic.

Jay Chalke said he welcomes Henry’s recent order that legally requires all long-term care homes to apply the visitor policy issued last month by the Health Ministry.

While Henry’s order expressly anticipates that changes to the policy may be needed, Chalke said he wants the ministry to make improvements because of his concerns about how it’s being implemented.

He called for mandatory timelines for decisions made by facility staff on requests for visits as well as for each stage of an appeals process. Care homes should also provide written reasons when visits are denied or restricted, he added.

“These shortcomings are unnecessarily amplifying an already difficult situation,” he said in a news release.

COVID-19 hit dozens of long-term care homes in the province and the outbreaks are responsible for the majority of deaths since the pandemic began.

Seniors advocate Isobel Mackenzie said all care-home residents are entitled to an essential visitor but some are only allowed one “designated” or social visitor who is denied access to the resident’s room.

Mackenzie said the decision on visitors should be left up to residents or whoever speaks for them, which she highlighted in a report in November.

“What we have is guidelines in place that allow for an essential visitor, but that does not guarantee that a resident will be allowed the essential visitor,” she said Monday.

The public health order issued Friday stipulates that residents who have an essential visitor should also get a designated or social visitor, Mackenzie said, adding the issue has caused confusion for care-home operators and the Fraser Health Authority in particular.

Mackenzie said families that have not been allowed an essential visitor have called her office to express their frustration and she’s concerned that those who have always helped feed and care for their loved ones have been treated as “an issue to be managed.”

READ MORE: Top doctor ‘dreading’ possibility that COVID variants will take off in B.C.

— By Camille Bains in Vancouver

The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.